[Federal Register Volume 64, Number 238 (Monday, December 13, 1999)]
[Notices]
[Page 69538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-32239]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Hematology and Pathology Devices Panel of the Medical Devices 
Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Hematology and Pathology Devices Panel of the 
Medical Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on December 15, 1999, 9 
a.m. to 4:30 p.m.
    Location: Corporate Bldg., conference room 20B, 9200 Corporate 
Blvd., Rockville, MD.
    Contact Person: Michelle Y. Stuart, Center for Devices and 
Radiological Health (HFZ-440), Food and Drug Administration, 2098 
Gaither Rd., Rockville, MD 20850, 301-594-1293, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12515. Please call the Information Line for 
up-to-date information on this meeting.
    Procedure: On December 15, 1999, from 9 a.m. to 10 a.m., the 
meeting is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
December 13, 1999. Those desiring to make formal oral presentations 
should notify the contact person by December 13, 1999, and submit a 
brief statement of the general nature of the evidence or arguments they 
wish to present, the names and addresses of proposed participants, and 
an indication of the approximate time requested to make their 
presentation. Time allotted for the presentations may be limited.
    Closed Committee Deliberations: On December 15, 1999, from 10 a.m. 
to 4:30 p.m., the meeting will be closed to the public. The committee 
will hear and review trade secret and/or confidential commercial 
information on a product development protocol (5 U.S.C. 552b(c)(4)). 
This portion of the meeting is closed to permit discussion of this 
information.
    FDA regrets that it was unable to publish this notice 15 days prior 
to the December 15, 1999, Hematology and Pathology Devices Panel of the 
Medical Devices Advisory Committee meeting. Because the agency believes 
there is some urgency to bring this issue to public discussion and 
qualified members of the Hematology and Pathology Devices Panel of the 
Medical Devices Advisory Committee were available at this time, the 
Commissioner concluded that it was in the public interest to hold this 
meeting even if there was not sufficient time for the customary 15-day 
public notice.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: December 7, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-32239 Filed 12-8-99; 4:55 pm]
BILLING CODE 4160-01-F